Neurology® Podcast

Dr. Stacey Clardy talks with Dr. Ken Tyler about misinformation about SARS-CoV2 & gives updates on antibody testing and ongoing clinical trials. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

In the first segment, Dr. Rae Bacharach talks with Dr. Karen Hirsch about her paper on the prognostic value of diffusion-weighted MRI for post-cardiac arrest coma. In the second part of the podcast, Dr. Teshamae Monteith speaks with Dr. Richard Lipton about his Neurology ® paper on eptinezumab for migraine, from the March 31st issue. Disclosures can be found at Neurology.org. CME Opportunity : Lis...

Dr. Jeff Ratliff talks with Dr. Anna Bersano about being a neurologist in Italy during the COVID-19 pandemic. Read Dr. Bersano's special editorial in Neurology: https://n.neurology.org/content/early/2020/04/01/WNL.0000000000009508 . For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

In this replay of a past Delayed Recall, Dr. Ted Burns talks with Dr. Dean Buonomano, author of  Brain Bugs , on how the brain makes and forgets memories.

In the first segment, Dr. Jason Crowell speaks with Dr. Andrew Southerland about Neurology on the Hill. In the second part of the podcast, Dr. Matthew Harms talks with Dr. Steve Vucic about his paper on multiple hit theory of ALS. Disclosures can be found at Neurology.org. CME Opportunity : Listen to this week's Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multip...

Dr. Teshamae Monteith talks with Dr. Joseph Kvedar about value-based care, e-consults, and telemedicine. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

Dr. Teshamae Monteith talks with Dr. Melissa Ko about telemedicine for neurologists caring for patients in light of COVID-19. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

In the first segment, Dr. Jeff Ratliff talks with Dr. Nico Dosenbach about his Neuron paper on neural networks and deep brain stimulation, and they specifically cover the Neurology Today article on this paper with respect to the impact on DBS. In the second part of the podcast, Dr. Jeff Ratliff speaks with Dr. Alberto Espay about his paper—from the March 17th issue of Neurology —on reconsidering b...

Dr. Ian Lipkin discusses his own diagnosis with COVID-19 and what neurologists can do in light of the pandemic to keep safe and to serve patients. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date. Find the cast of Contagion's PSAs on the pandemic: https://abcnews.go.com/Entertainment/cast-contagion-issues-psa-coronavirus-pandemic/sto...

In the first segment, Dr. Jason Crowell talks with Dr. Daniel Hartung about his paper on the effect of generic glatiramer acetate on the reduction of MS costs. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Brian Callaghan about his paper—also from the March 31st issue of Neurology —on the association between out-of-pocket costs and adherence to common neurologic medications....

Dr. Avindra Nath provides a special report on what clinicians need to know about neurologic symptoms and complications of COVID-19. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

In the first segment, Dr. Matthew Barrett talks with Dr. John-Paul Taylor about his paper on Lewy body dementia management, from The Lancet . In the second part of the podcast, Dr. Stacey Clardy speaks with Dr. Chris Butler about his paper on pathologic tearfulness after limbic encephalitis. You can read Dr. Taylor's paper in The Lancet here: https://www.thelancet.com/journals/laneur/article/PIIS1...

Dr. Jason Crowell speaks with Dr. John Noseworthy on his NEJM article on preserving the physician-patient relationship, which you can read here: https://www.nejm.org/doi/full/10.1056/NEJMsr1912662.

Dr. Halley Alexander talks with Dr. Emma Foster about her Neurology paper discussing that antiepileptic drugs are not independently associated with cognitive dysfunction. Disclosures can be found at Neurology.org. CME Opportunity : Listen to this week's Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Dr. Jason Crowell speaks with Denise Roland of the Wall Street Journal about her story on an obscure model driving down drug costs. You can read their paper in the Wall Street Journal here: https://www.wsj.com/articles/obscure-model-puts-a-price-on-good-healthand-drives-down-drug-costs-11572885123 .

This month's Delayed Recall highlights 6 interviews on encephalopathies from the March and April 2013 Delayed Recall episodes. You'll hear about encephalopathies caused by endocrine disorders, by electrolyte disorders, by liver and kidney failure, and by other organ failure. The other interviews cover encephalopathies caused by systemic disease, such as encephalopathies caused by drugs or miscella...

Dr. Stacey Clardy talks with Dr. Robert Silbergleit and Dr. Jaideep Kapur about anticonvulsant medications for status epilepticus. You can read Dr. Silbergleit and Dr. Kapur's paper in the New England Journal of Medicine here: https://www.nejm.org/doi/full/10.1056/NEJMoa1905795.

Dr. Stacey Clardy talks with Dr. Ken Tyler about infectious encephalitis and arthropod-borne infections in 2019.

In the first interview, Dr. Teshamae Monteith talks with Dr. Francesca Puledda about her paper on clinical and phenotypical descriptions of visual snow syndrome patients. In the second interview, Dr. Jason Crowell talks with Ed Silverman about the settlement over allegations a patient charity helped drug makers pay kickbacks to Medicare patients over MS drugs. You can read the STAT article here: h...

In the first segment, Dr. Jason Crowell talks with Dr. Timothy Yu about patient-customized oligonucleotide therapy for a rare genetic disease. In the second part of the podcast, Dr. Jeffrey Burns talks with Dr. Amy Sanders about her implementation update on quality improvement in dementia care. You can read Dr. Yu's paper in the NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa1813279 . Disclosur...

This month's Delayed Recall highlights episodes on CTE and head trauma. Dr. Jason Crowell talks with Dr. Jesse Mez on his work on chronic traumatic encephalopathy and American football players, from the August 29, 2017. The next segment, from January 21, 2020, features Dr. Jeff Ratliff interviewing Dr. Charles Bernick on MRI biomarkers in boxers and MMA fighters. Next, from April 3, 2018, Dr. Lee...

Dr. Jason Crowell talks with Dr. Daniel Hartung about his qualitative study on drug prices for MS.

In the first segment, Dr. Jeffrey Ratliff talks with Dr. Charles Bernick about his paper on longitudinal change in regional brain volumes with exposure to repetitive head impacts. In the second part of the podcast, Dr. Teshamae Monteith talks with Dr. Amy Gelfand about infant colic and episodic syndromes. Disclosures can be found at Neurology.org. CME Opportunity : Listen to this week's Neurology...

In the first segment, Dr. Stacey Clardy talks with Dr. Francesc Graus and Dr. Josep Dalmau about their paper on Hashimoto encephalopathy in the 21st century. In the second part of the podcast, Dr. Teshamae Monteith talks with Dr. Richard Lipton and Dr. Dawn Buse about migraine progression in subgroups of migraine based on comorbidities.

Dr. Michelle Mauermann talks with Dr. Mary Reilly about her paper on targeted, next-generation, sequencing panels in the diagnosis of Charcot-Marie-Tooth disease.